Fund Overview of Tata India Pharma & Healthcare Fund Direct-growth
-
₹1,229.4 CrAUM
-
₹36.92NAV
-
1.65%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Tata India Pharma & Healthcare Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 8.57% | NA | 6.12% |
| 6 Months | 2.60% | NA | 12.92% |
| 1 Year | 9.03% | 9.03% | 6.04% |
| 2 Years | 28.10% | 13.18% | 24.93% |
| 3 Years | 97.77% | 25.52% | 25.71% |
| 5 Years | 106.61% | 15.62% | 19.91% |
| 7 Years | 282.87% | 21.14% | NA |
| 10 Years | 286.20% | 14.47% | 12.78% |
Asset Allocation
equities
99.69%other assets or cash equivalents
0.31%Tata India Pharma & Healthcare Fund Direct-growth is one Equity mutual fund offered by Tata Mutual Fund. Launched on 28 Dec 2015, the fund aims Long Term Capital Appreciation. Investment in equity/equity related instruments of the companies in the Pharma & Healthcare sector in India. It manages assets worth ₹1,229.4 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.65%. Fund Manager Manager EducationAbout Tata India Pharma & Healthcare Fund Direct-growth
The portfolio allocation consists of 99.69% in equities, 0.31% in other assets or cash equivalents.Managed by Rajat Srivastava, it has delivered a return of 9.03% in the last year, a total return since inception of 13.38%.
For those looking to make well-planned financial choices it helps to compare best sip to invest suited to long-term goals.
Key Metrics of Tata India Pharma & Healthcare Fund Direct-growth
-
Standard Deviation15.97%
-
Sharpe Ratio1.09%
-
Alpha0.79%
-
Beta0.98%
Fund Details
|
|
Top Performing Mutual Funds
More funds from Tata Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Tata India Pharma & Healthcare Fund Regular-growth
|
₹1,229 | 10.91% | 8.20% | 1.87% | 7.45% | 23.70% |
|
Tata India Pharma & Healthcare Fund Regular-idcw
|
₹1,229 | 10.91% | 8.20% | 1.87% | 7.45% | 23.70% |
|
Tata India Pharma & Healthcare Fund Direct-idcw
|
₹1,229 | 11.04% | 8.57% | 2.60% | 9.03% | 25.52% |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-growth
|
₹153 | 12.86% | 14.72% | 7.60% | 15.08% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-growth
|
₹153 | 12.91% | 14.88% | 7.93% | 15.79% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-idcw
|
₹153 | 12.86% | 14.72% | 7.60% | 15.08% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-idcw
|
₹153 | 12.91% | 14.88% | 7.93% | 15.79% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹537.83 | 23.67% | 13.51% | 14.97% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹603.39 | 24.79% | 14.54% | 16.00% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹116.14 | 23.67% | 13.51% | 14.97% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹165.14 | 24.79% | 14.54% | 16.00% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹41.50 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹45.01 | 29.60% | 17.49% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹24.21 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹27.18 | 29.60% | 17.49% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹455.80 | 26.16% | 15.84% | 12.77% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹526.21 | 27.48% | 17.07% | 14.01% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.92% | ₹146.17 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.03% | ₹130.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.03% | ₹130.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.34% | ₹127.07 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.66% | ₹125.61 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.31% | ₹115.36 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.75% | ₹103.73 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.88% | ₹103.31 Cr |
| Cipla Ltd | Healthcare | 6.62% | ₹88.60 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.78% | ₹88.23 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.24% | ₹77.31 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.94% | ₹77.29 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.87% | ₹76.99 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.65% | ₹75.70 Cr |
| Abbott India Ltd | Healthcare | 5.98% | ₹74.10 Cr |
| Abbott India Ltd | Healthcare | 5.60% | ₹72.83 Cr |
| Abbott India Ltd | Healthcare | 5.89% | ₹72.44 Cr |
| Abbott India Ltd | Healthcare | 5.48% | ₹71.85 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.83% | ₹71.72 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.20% | ₹69.60 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.13% | ₹68.62 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.13% | ₹68.00 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.13% | ₹68.00 Cr |
| Abbott India Ltd | Healthcare | 5.04% | ₹67.51 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.37% | ₹66.59 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.39% | ₹66.27 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.96% | ₹65.76 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.96% | ₹65.76 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.01% | ₹65.66 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.04% | ₹65.61 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.06% | ₹65.59 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.06% | ₹65.59 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.00% | ₹65.04 Cr |
| Lupin Ltd | Healthcare | 4.90% | ₹64.97 Cr |
| Lupin Ltd | Healthcare | 4.90% | ₹64.97 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.85% | ₹64.94 Cr |
| Lupin Ltd | Healthcare | 4.77% | ₹63.83 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.14% | ₹63.67 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.84% | ₹63.46 Cr |
| Lupin Ltd | Healthcare | 4.88% | ₹63.24 Cr |
| Lupin Ltd | Healthcare | 4.88% | ₹63.24 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.14% | ₹63.20 Cr |
| Cipla Ltd | Healthcare | 4.86% | ₹62.97 Cr |
| Cipla Ltd | Healthcare | 4.86% | ₹62.97 Cr |
| Cipla Ltd | Healthcare | 5.10% | ₹62.75 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.71% | ₹62.44 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.71% | ₹62.44 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.76% | ₹62.35 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.97% | ₹61.62 Cr |
| Repo | Unspecified | 4.56% | ₹61.10 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.68% | ₹60.68 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.68% | ₹60.68 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.68% | ₹60.63 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.68% | ₹60.63 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.63% | ₹60.00 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.63% | ₹60.00 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.52% | ₹59.95 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.52% | ₹59.95 Cr |
| Cipla Ltd | Healthcare | 4.55% | ₹59.16 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.38% | ₹58.63 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.42% | ₹58.61 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.42% | ₹58.61 Cr |
| Cipla Ltd | Healthcare | 4.69% | ₹58.10 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.32% | ₹57.89 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.32% | ₹57.89 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.46% | ₹57.74 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.46% | ₹57.74 Cr |
| Cipla Ltd | Healthcare | 4.14% | ₹54.29 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.00% | ₹53.56 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.00% | ₹53.55 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.99% | ₹53.46 Cr |
| Abbott India Ltd | Healthcare | 4.02% | ₹53.31 Cr |
| Abbott India Ltd | Healthcare | 4.02% | ₹53.31 Cr |
| Cipla Ltd | Healthcare | 3.96% | ₹53.00 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.25% | ₹52.29 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 4.23% | ₹52.01 Cr |
| Cipla Ltd | Healthcare | 3.92% | ₹51.96 Cr |
| Cipla Ltd | Healthcare | 3.92% | ₹51.96 Cr |
| Max Healthcare Institute Ltd | Healthcare | 3.95% | ₹51.13 Cr |
| Max Healthcare Institute Ltd | Healthcare | 3.95% | ₹51.13 Cr |
| Max Healthcare Institute Ltd | Healthcare | 3.80% | ₹50.83 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.78% | ₹50.58 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.86% | ₹50.02 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.86% | ₹50.02 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.83% | ₹49.84 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.77% | ₹49.41 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.72% | ₹48.79 Cr |
| Lupin Ltd | Healthcare | 3.57% | ₹47.75 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.56% | ₹47.12 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.56% | ₹47.12 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.75% | ₹46.48 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.52% | ₹46.17 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.45% | ₹46.15 Cr |
| Wockhardt Ltd | Healthcare | 3.42% | ₹45.83 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.48% | ₹45.58 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.36% | ₹44.94 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.35% | ₹44.43 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.35% | ₹44.43 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.40% | ₹44.27 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.57% | ₹43.94 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.30% | ₹43.70 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.30% | ₹43.70 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.29% | ₹43.60 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.29% | ₹43.60 Cr |
| Bayer Cropscience Ltd | Materials | 3.33% | ₹43.37 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.30% | ₹43.27 Cr |
| Bayer Cropscience Ltd | Materials | 3.23% | ₹43.24 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.26% | ₹43.19 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.26% | ₹43.19 Cr |
| Bayer Cropscience Ltd | Materials | 3.51% | ₹43.12 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.22% | ₹42.68 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.22% | ₹42.68 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.27% | ₹42.56 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.45% | ₹42.36 Cr |
| Sai Life Sciences Ltd. | Healthcare | 3.25% | ₹42.33 Cr |
| Bayer Cropscience Ltd | Materials | 3.23% | ₹42.31 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.18% | ₹42.10 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.18% | ₹42.10 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.38% | ₹41.84 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.21% | ₹41.71 Cr |
| Wockhardt Ltd | Healthcare | 3.22% | ₹41.67 Cr |
| Wockhardt Ltd | Healthcare | 3.22% | ₹41.67 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.20% | ₹41.52 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.20% | ₹41.52 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.10% | ₹41.52 Cr |
| Bayer Cropscience Ltd | Materials | 3.34% | ₹41.46 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.08% | ₹41.26 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.15% | ₹41.22 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.06% | ₹40.98 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.13% | ₹40.68 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.00% | ₹40.13 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹40.11 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.23% | ₹40.02 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.05% | ₹39.91 Cr |
| Lupin Ltd | Healthcare | 3.04% | ₹39.89 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.04% | ₹39.60 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.95% | ₹39.45 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.15% | ₹39.11 Cr |
| Lupin Ltd | Healthcare | 3.18% | ₹39.05 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.17% | ₹38.95 Cr |
| Fdc Ltd | Healthcare | 2.93% | ₹38.77 Cr |
| Fdc Ltd | Healthcare | 2.93% | ₹38.77 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.96% | ₹38.76 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.11% | ₹38.59 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.98% | ₹38.57 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.98% | ₹38.57 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.97% | ₹38.53 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.97% | ₹38.53 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.87% | ₹38.48 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.10% | ₹38.44 Cr |
| Fdc Ltd | Healthcare | 2.87% | ₹38.42 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.89% | ₹38.29 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.89% | ₹38.29 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.85% | ₹38.09 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.84% | ₹38.08 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.94% | ₹38.08 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.94% | ₹38.08 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.06% | ₹37.97 Cr |
| Abbott India Ltd | Healthcare | 2.90% | ₹37.64 Cr |
| Abbott India Ltd | Healthcare | 2.90% | ₹37.64 Cr |
| Lupin Ltd | Healthcare | 3.03% | ₹37.51 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.85% | ₹37.37 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.02% | ₹37.09 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.82% | ₹36.90 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.82% | ₹36.51 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.82% | ₹36.51 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.71% | ₹36.24 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.77% | ₹36.24 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.67% | ₹35.70 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.87% | ₹35.52 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.71% | ₹35.28 Cr |
| Cash/net Current Assets | Unspecified | 2.61% | ₹35.25 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.61% | ₹34.90 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.63% | ₹34.81 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.63% | ₹34.81 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.59% | ₹34.63 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.64% | ₹34.36 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.77% | ₹34.29 Cr |
| Pi Industries Ltd | Materials | 2.64% | ₹34.16 Cr |
| Pi Industries Ltd | Materials | 2.64% | ₹34.16 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.69% | ₹33.07 Cr |
| Syngene International Ltd | Healthcare | 2.64% | ₹32.48 Cr |
| Repo | Unspecified | 2.39% | ₹32.01 Cr |
| Syngene International Ltd | Healthcare | 2.42% | ₹31.77 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.58% | ₹31.69 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.55% | ₹31.63 Cr |
| Syngene International Ltd | Healthcare | 2.35% | ₹31.43 Cr |
| Syngene International Ltd | Healthcare | 2.39% | ₹31.15 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.39% | ₹30.94 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.39% | ₹30.94 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.33% | ₹30.87 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.33% | ₹30.87 Cr |
| Syngene International Ltd | Healthcare | 2.46% | ₹30.43 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.33% | ₹30.14 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.33% | ₹30.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.45% | ₹30.14 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.23% | ₹29.84 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.40% | ₹29.56 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.17% | ₹28.81 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.17% | ₹28.81 Cr |
| Pi Industries Ltd | Materials | 2.17% | ₹28.78 Cr |
| Pi Industries Ltd | Materials | 2.17% | ₹28.78 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.15% | ₹28.72 Cr |
| Cash/net Current Assets | Unspecified | 2.24% | ₹28.68 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.10% | ₹28.17 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.15% | ₹28.01 Cr |
| Fdc Ltd | Healthcare | 2.14% | ₹27.79 Cr |
| Fdc Ltd | Healthcare | 2.14% | ₹27.79 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.09% | ₹27.63 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.09% | ₹27.63 Cr |
| Fdc Ltd | Healthcare | 2.04% | ₹27.37 Cr |
| Fdc Ltd | Healthcare | 2.08% | ₹27.32 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.01% | ₹26.87 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.06% | ₹26.77 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.16% | ₹26.73 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.99% | ₹26.63 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.01% | ₹26.57 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.01% | ₹26.57 Cr |
| Sanofi India Ltd | Healthcare | 2.02% | ₹26.45 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.14% | ₹26.35 Cr |
| Sanofi India Ltd | Healthcare | 2.12% | ₹26.22 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.00% | ₹25.99 Cr |
| Sanofi India Ltd | Healthcare | 1.99% | ₹25.88 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.08% | ₹25.57 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.90% | ₹25.46 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 1.88% | ₹25.12 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.04% | ₹25.08 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.91% | ₹24.77 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.91% | ₹24.77 Cr |
| Global Health Ltd | Healthcare | 2.01% | ₹24.66 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.84% | ₹24.60 Cr |
| Fdc Ltd | Healthcare | 1.97% | ₹24.39 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.82% | ₹23.84 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.82% | ₹23.72 Cr |
| Fdc Ltd | Healthcare | 1.82% | ₹23.64 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.76% | ₹23.60 Cr |
| Syngene International Ltd | Healthcare | 1.76% | ₹23.37 Cr |
| Syngene International Ltd | Healthcare | 1.76% | ₹23.37 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.75% | ₹22.99 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.77% | ₹22.93 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.77% | ₹22.93 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.70% | ₹22.77 Cr |
| Fdc Ltd | Healthcare | 1.84% | ₹22.61 Cr |
| Syngene International Ltd | Healthcare | 1.73% | ₹22.39 Cr |
| Syngene International Ltd | Healthcare | 1.73% | ₹22.39 Cr |
| Cash/net Current Assets | Unspecified | 1.63% | ₹22.13 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.71% | ₹22.13 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.71% | ₹22.13 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.78% | ₹22.03 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.64% | ₹21.98 Cr |
| Niva Bupa Health Insurance Company Ltd. | Financial | 1.63% | ₹21.89 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.63% | ₹21.66 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.63% | ₹21.66 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.63% | ₹21.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.71% | ₹21.22 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.61% | ₹21.16 Cr |
| Syngene International Ltd | Healthcare | 1.58% | ₹21.13 Cr |
| Sanofi India Ltd | Healthcare | 1.70% | ₹20.95 Cr |
| Niva Bupa Health Insurance Company Ltd. | Financial | 1.58% | ₹20.46 Cr |
| Niva Bupa Health Insurance Company Ltd. | Financial | 1.58% | ₹20.46 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.55% | ₹20.17 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.55% | ₹20.08 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.55% | ₹20.08 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.50% | ₹20.04 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.51% | ₹20.02 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.51% | ₹20.02 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.50% | ₹19.85 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.50% | ₹19.85 Cr |
| Cash/net Current Assets | Unspecified | 1.53% | ₹19.85 Cr |
| Cash/net Current Assets | Unspecified | 1.53% | ₹19.85 Cr |
| Global Health Ltd | Healthcare | 1.50% | ₹19.57 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.55% | ₹19.25 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.52% | ₹18.80 Cr |
| Wockhardt Ltd | Healthcare | 1.41% | ₹18.74 Cr |
| Wockhardt Ltd | Healthcare | 1.41% | ₹18.74 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.41% | ₹18.28 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.41% | ₹18.28 Cr |
| Wockhardt Ltd | Healthcare | 1.35% | ₹18.06 Cr |
| Global Health Ltd | Healthcare | 1.42% | ₹17.55 Cr |
| Corona Remedies Ltd. | 1.40% | ₹17.30 Cr | |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.41% | ₹17.30 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.34% | ₹16.48 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 1.22% | ₹16.34 Cr |
| Corona Remedies Ltd. | 1.24% | ₹16.20 Cr | |
| Cash/net Current Assets | Unspecified | 1.18% | ₹15.42 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.22% | ₹15.16 Cr |
| Global Health Ltd | Healthcare | 1.14% | ₹14.94 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.20% | ₹14.74 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.12% | ₹14.74 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.08% | ₹13.98 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.08% | ₹13.98 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.07% | ₹13.90 Cr |
| Indoco Remedies Ltd | Healthcare | 1.02% | ₹13.62 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.10% | ₹13.54 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 1.00% | ₹13.36 Cr |
| Zydus Lifesciences Ltd | Healthcare | 0.99% | ₹13.31 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.02% | ₹13.26 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.02% | ₹13.26 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 0.97% | ₹13.05 Cr |
| Repo | Unspecified | 0.98% | ₹12.98 Cr |
| Repo | Unspecified | 0.98% | ₹12.98 Cr |
| Corona Remedies Ltd. | 0.99% | ₹12.93 Cr | |
| Pi Industries Ltd | Materials | 0.91% | ₹12.25 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹11.86 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹11.86 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 0.87% | ₹11.64 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.88% | ₹11.36 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.88% | ₹11.36 Cr |
| Medplus Health Services Ltd | Healthcare | 0.83% | ₹11.06 Cr |
| Hikal Ltd | Healthcare | 0.76% | ₹10.22 Cr |
| Hikal Ltd | Healthcare | 0.76% | ₹9.91 Cr |
| Hikal Ltd | Healthcare | 0.76% | ₹9.91 Cr |
| Wockhardt Ltd | Healthcare | 0.72% | ₹9.48 Cr |
| Hikal Ltd | Healthcare | 0.71% | ₹9.39 Cr |
| Hikal Ltd | Healthcare | 0.71% | ₹9.39 Cr |
| Cash/net Current Assets | Unspecified | 0.72% | ₹9.27 Cr |
| Corona Remedies Ltd. | 0.75% | ₹9.21 Cr | |
| Medplus Health Services Ltd | Healthcare | 0.69% | ₹9.00 Cr |
| Medplus Health Services Ltd | Healthcare | 0.69% | ₹9.00 Cr |
| Hikal Ltd | Healthcare | 0.68% | ₹8.93 Cr |
| Hikal Ltd | Healthcare | 0.66% | ₹8.78 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.70% | ₹8.57 Cr |
| Hikal Ltd | Healthcare | 0.60% | ₹7.75 Cr |
| Pi Industries Ltd | Materials | 0.63% | ₹7.71 Cr |
| Hdfc Life Insurance Co Ltd | Financial | 0.62% | ₹7.68 Cr |
| Hikal Ltd | Healthcare | 0.61% | ₹7.58 Cr |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.53% | ₹7.11 Cr |
| Cash/net Current Assets | Unspecified | 0.55% | ₹6.85 Cr |
| Cash/net Current Assets | Unspecified | 0.55% | ₹6.85 Cr |
| Tata Chemicals Ltd | Materials | 0.50% | ₹6.20 Cr |
| Ami Organics Ltd | Healthcare | 0.46% | ₹6.11 Cr |
| Pi Industries Ltd | Materials | 0.46% | ₹5.98 Cr |
| Pfizer Ltd | Healthcare | 0.42% | ₹5.53 Cr |
| Pfizer Ltd | Healthcare | 0.42% | ₹5.53 Cr |
| Pfizer Ltd | Healthcare | 0.41% | ₹5.35 Cr |
| Pfizer Ltd | Healthcare | 0.41% | ₹5.35 Cr |
| Sumitomo Chemical India Ltd | Materials | 0.39% | ₹4.81 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.34% | ₹4.15 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.26% | ₹3.35 Cr |
| Repo | Unspecified | 0.26% | ₹3.21 Cr |
| Repo | Unspecified | 0.20% | ₹2.61 Cr |
| Repo | Unspecified | 0.19% | ₹2.43 Cr |
| Repo | Unspecified | 0.19% | ₹2.43 Cr |
| Repo | Unspecified | 0.18% | ₹2.22 Cr |
| Repo | Unspecified | 0.14% | ₹1.82 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 0.09% | ₹1.20 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 0.08% | ₹1.05 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 0.08% | ₹1.05 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.07% | ₹0.93 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.07% | ₹0.91 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.07% | ₹0.87 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.07% | ₹0.82 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.75 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.75 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.74 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.73 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.05% | ₹0.66 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.05% | ₹0.61 Cr |
| Indoco Remedies Ltd | Healthcare | 0.04% | ₹0.57 Cr |
| Indoco Remedies Ltd | Healthcare | 0.04% | ₹0.57 Cr |
| Cash/net Current Assets | Unspecified | 0.05% | ₹0.54 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.04% | ₹0.47 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.04% | ₹0.47 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.45 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.45 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.40 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.39 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.02% | ₹0.28 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.02% | ₹0.27 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.00% | ₹0.04 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.00% | ₹0.04 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹45.01 | 29.60% | 17.49% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹27.18 | 29.60% | 17.49% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹526.21 | 27.48% | 17.07% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹365.60 | 27.48% | 17.07% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.15 | 27.16% | 16.47% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.40 | 27.16% | 16.47% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹41.50 | 28.51% | 16.46% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹24.21 | 28.51% | 16.46% | - |
| SBI Healthcare Opportunities Fund-growth |
₹455.80 | 26.16% | 15.84% | - |
| SBI Healthcare Opportunities Fund-idcw |
₹287.13 | 26.16% | 15.84% | - |
Frequently Asked Questions
Tata India Pharma & Healthcare Fund Direct-growth
What is the current AUM of Tata India Pharma & Healthcare Fund Direct-growth?
As of Tue Mar 31, 2026, Tata India Pharma & Healthcare Fund Direct-growth manages assets worth ₹1,229.4 crore
How has Tata India Pharma & Healthcare Fund Direct-growth performed recently?
- 3 Months: 8.57%
- 6 Months: 2.60%
What is the long-term performance of Tata India Pharma & Healthcare Fund Direct-growth?
- 3 Years CAGR: 25.52%
- 5 Years CAGR: 15.62%
- Since Inception: 13.38%
What is the portfolio composition of Tata India Pharma & Healthcare Fund Direct-growth?
Equity: 99.69%, Others: 0.31%.
Who manages Tata India Pharma & Healthcare Fund Direct-growth?
Tata India Pharma & Healthcare Fund Direct-growth is managed by Rajat Srivastava from Tata Mutual Fund.
What is the market-cap allocation of Tata India Pharma & Healthcare Fund Direct-growth?
Large Cap: 35.94%, Mid Cap: 24.32%, Small Cap: 39.74%.
Which are the top companies Tata India Pharma & Healthcare Fund Direct-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 10.92% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.03% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.03% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.59% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.59% of the fund's portfolio
Which are the major sectors Tata India Pharma & Healthcare Fund Direct-growth focuses on?
- Healthcare – 937.44% of the fund's portfolio
- Materials – 29.15% of the fund's portfolio
- Unspecified – 22.66% of the fund's portfolio
- Financial – 5.41% of the fund's portfolio
- Other – 4.38% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





